GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medtronic MDT · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

102.79

+0.97%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medtronic

From its filings with the US Securities and Exchange Commission

SEC filings

Medtronic is based in Galway. Its shares trade on NYSE under the ticker MDT. It is a member of the S&P 500. The SEC classifies its business as electromedical & electrotherapeutic apparatus. In the fiscal year to 24 April 2026, it reported revenue of $36.36bn and net income of $4.80bn. At that date it held total assets of $93.03bn and shareholders' equity of $49.46bn.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
17 Mar 1980
Employees
95,000
Head office
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, H91 4K49
Classification
Electromedical & Electrotherapeutic Apparatus
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Geoffrey MarthaExecutive Chairman of the Board, Chief Executive Officer, since 2011$21.2m
  • Mr. Thierry PietonChief Financial Officer, Executive Vice President$5.2m
  • Mr. Matthew WalterChief Human Resources Officer, Senior Vice President
  • Mr. Ivan FongExecutive Vice President, General Counsel, Corporate Secretary$11.7m
  • Mr. Skip KiilExecutive Vice President, President - Cardiovascular Portfolio
  • Mr. Michael MarinaroExecutive Vice President, President - Medical Surgical Portfolio and Americas
  • Mr. Gregory SmithExecutive Vice President - Enterprise Operations$8.1m
  • Mr. Brett WallExecutive Vice President, President - Neuroscience Portfolio$8.1m
  • Mr. Craig ArnoldLead Independent Director$410,055
  • Mr. Scott DonnellyIndependent Director$365,055
  • Ms. Lidia FonsecaIndependent Director$350,055
  • Mr. John GroetelaarsIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
70
Environment
74
Social
85
Governance
52
Direct emissions (scope 1)
99,000 t
Energy emissions (scope 2)
118,000 t
Value chain emissions (scope 3)
3,213,000 t
Women in the workforce
51%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medtronic PLC holds a strong position in the medical technology industry, exhibiting several notable strengths:
  • Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:
  • Medtronic PLC has various opportunities to leverage and expand its business:
  • Medtronic PLC faces several threats that may impact its performance and market position:

Weaknesses

  • Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:
  • Medtronic PLC has various opportunities to leverage and expand its business:
  • Medtronic PLC faces several threats that may impact its performance and market position:

Opportunities

  • Medtronic PLC has various opportunities to leverage and expand its business:
  • Medtronic PLC faces several threats that may impact its performance and market position:

Threats

  • Medtronic PLC faces several threats that may impact its performance and market position:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.